Atlas Trials

Confirm the Effectiveness of Predictix Genetics Antidepressant -Guided Treatment in Adults With MDD

Clinical trial NCT05137197 · UNKNOWN

Trial details

NCT number
NCT05137197
Sponsor
Taliaz Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2021-10-04
Primary completion
2023-12-01
Enrollment
354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.